These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 30773595)
1. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex. Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595 [TBL] [Abstract][Full Text] [Related]
2. Determining the prognostic significance of IKKα in prostate cancer. Montes M; MacKenzie L; McAllister MJ; Roseweir A; McCall P; Hatziieremia S; Underwood MA; Boyd M; Paul A; Plevin R; MacKay SP; Edwards J Prostate; 2020 Oct; 80(14):1188-1202. PubMed ID: 33258506 [TBL] [Abstract][Full Text] [Related]
3. Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. Benelli R; Barboro P; Costa D; Astigiano S; Barbieri O; Capaia M; Poggi A; Ferrari N Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816863 [TBL] [Abstract][Full Text] [Related]
4. FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP. Tufano M; Marrone L; D'Ambrosio C; Di Giacomo V; Urzini S; Xiao Y; Matuozzo M; Scaloni A; Romano MF; Romano S Cell Death Dis; 2023 Feb; 14(2):116. PubMed ID: 36781840 [TBL] [Abstract][Full Text] [Related]
5. LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway. Liu SY; Zhao ZY; Qiao Z; Li SM; Zhang WN Cell Transplant; 2021; 30():963689720986071. PubMed ID: 33461333 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation. Saha S; Kiran M; Kuscu C; Chatrath A; Wotton D; Mayo MW; Dutta A Cancer Res; 2020 Mar; 80(5):950-963. PubMed ID: 31900260 [TBL] [Abstract][Full Text] [Related]
9. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer. Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736 [TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Parolia A; Venalainen E; Xue H; Mather R; Lin D; Wu R; Pucci P; Rogalski J; Evans JR; Feng F; Collins CC; Wang Y; Crea F Mol Oncol; 2019 May; 13(5):1121-1136. PubMed ID: 30776192 [TBL] [Abstract][Full Text] [Related]
11. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247 [TBL] [Abstract][Full Text] [Related]
12. BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance. Cai Z; Wu Y; Li Y; Ren J; Wang L Aging (Albany NY); 2018 Dec; 10(12):3702-3712. PubMed ID: 30513511 [TBL] [Abstract][Full Text] [Related]
13. Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability. Matsumoto H; Yamamoto Y; Shiota M; Kuruma H; Beraldi E; Matsuyama H; Zoubeidi A; Gleave M Cancer Res; 2013 Aug; 73(16):5206-17. PubMed ID: 23786771 [TBL] [Abstract][Full Text] [Related]
14. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer. Thamilselvan V; Menon M; Thamilselvan S Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552 [TBL] [Abstract][Full Text] [Related]
15. Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer. Yu J; Sun L; Hao T; Zhang B; Chen X; Li H; Zhang Z; Zhu S; Quan C; Niu Y; Shang Z Ann Transl Med; 2019 Dec; 7(23):729. PubMed ID: 32042745 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Wang D; Ding L; Wang L; Zhao Y; Sun Z; Karnes RJ; Zhang J; Huang H Oncotarget; 2015 Dec; 6(38):41045-55. PubMed ID: 26516927 [TBL] [Abstract][Full Text] [Related]
17. Assembly of the FKBP51-PHLPP2-AKT signaling complex in cerebral ischemia/reperfusion injury in rats. Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ Brain Res; 2014 May; 1566():60-8. PubMed ID: 24746496 [TBL] [Abstract][Full Text] [Related]
18. Crosstalk of NF-κB/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment. Xiang S; Zou P; Wu J; Zheng F; Tang Q; Zhou J; Hann SS Cell Physiol Biochem; 2018; 47(2):759-773. PubMed ID: 29807357 [TBL] [Abstract][Full Text] [Related]
19. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5. Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115 [TBL] [Abstract][Full Text] [Related]
20. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA. Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]